StockNews.com Begins Coverage on LifeVantage (NASDAQ:LFVN)

Equities researchers at StockNews.com began coverage on shares of LifeVantage (NASDAQ:LFVNGet Rating) in a note issued to investors on Monday. The firm set a “buy” rating on the stock.

LifeVantage Stock Performance

Shares of NASDAQ:LFVN opened at $3.84 on Monday. The stock has a market capitalization of $48.20 million, a price-to-earnings ratio of 16.00 and a beta of 1.22. The stock’s 50-day simple moving average is $4.08 and its two-hundred day simple moving average is $4.36. LifeVantage has a 52-week low of $3.59 and a 52-week high of $7.70.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Private Advisor Group LLC bought a new stake in LifeVantage during the 2nd quarter valued at approximately $49,000. Victory Capital Management Inc. raised its stake in LifeVantage by 30.4% during the 1st quarter. Victory Capital Management Inc. now owns 13,868 shares of the company’s stock valued at $66,000 after purchasing an additional 3,235 shares during the period. Campbell & CO Investment Adviser LLC raised its stake in LifeVantage by 117.2% during the 1st quarter. Campbell & CO Investment Adviser LLC now owns 21,717 shares of the company’s stock valued at $103,000 after purchasing an additional 11,717 shares during the period. O Shaughnessy Asset Management LLC raised its stake in LifeVantage by 49.8% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 23,461 shares of the company’s stock valued at $148,000 after purchasing an additional 7,804 shares during the period. Finally, American Century Companies Inc. raised its stake in LifeVantage by 30.3% during the 1st quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock valued at $219,000 after purchasing an additional 10,706 shares during the period. 27.06% of the stock is owned by hedge funds and other institutional investors.

LifeVantage Company Profile

(Get Rating)

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Featured Stories

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.